Advertisement

HindustanTimes Thu,02 Oct 2014

Dr Reddy's Q3 profit jumps 70.21% to Rs. 618.42cr

PTI  New Delhi, February 11, 2014
First Published: 16:44 IST(11/2/2014) | Last Updated: 16:49 IST(11/2/2014)

Dr Reddy's Laboratories on Tuesday reported a 70.21% increase in its consolidated net profit at Rs. 618.42 crore for the third quarter ended December 31, 2013.


Advertisement

The company had posted a consolidated profit of Rs. 363.31 crore in the same period of the previous financial year.

Consolidated net sales rose to Rs. 3,533.76 crore in the quarter under review from Rs. 2,865.16 crore a year earlier, Dr Reddy's Laboratories said in a BSE filing.

Revenue from the global generics segment grew to Rs. 2,939.58 crore in the December quarter of 2013 as against Rs. 2,082.77 crore in the corresponding period a year ago, driven by North America, Russia and other emerging markets.

Shares of Dr Reddy's Laboratories were trading at Rs. 2668.15 per scrip during the afternoon trade at BSE, down 0.32% from its previous close.


Advertisement
more from Business

Vijay Mallya has to clear loan defaults to serve as USL chairman: Diageo

Loan default cases against Vijay Mallya and his UB Group may cast a shadow over his continuation as chairman of United Spirits Ltd in the future, with its current parent, UK-based Diageo, making it clear in a statement from its headquarters in London.

markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved